Hepatitis C in Brazil: lessons learned with boceprevir and telaprevir

In 2012, the first-generation protease inhibitors telaprevir (TVR) and boceprevir (BOC) were introduced in the Brazilian health system for treatment of chronic hepatitis C, after their approval by the National Committee for Health Technology Incorporation (CONITEC). However, these medicines were dis...

全面介紹

Na minha lista:
書目詳細資料
發表在:Rev Inst Med Trop Sao Paulo
Main Authors: Gomes, Lenyta Oliveira, Teixeira, Marina Rodrigues, da Rosa, Júnior André, Feltrin, Alberi Adolfo, Rodrigues, João Paulo V., Vecchi, Mariane D’Avila, Carneiro, Jane Meire M., Noblat, Lúcia de Araújo C. B., Chachá, Silvana Gama F., Martinelli, Ana de Lourdes C., Pereira, Leonardo Regis L., Silveira, Marysabel Pinto T., Blatt, Carine Raquel, Farias, Mareni Rocha
格式: Artigo
語言:Inglês
出版: Instituto de Medicina Tropical 2018
主題:
Original Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC6029893/
https://ncbi.nlm.nih.gov/pubmed/29972466
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1590/S1678-9946201860029
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍